First DXM Age Law Passes While Voluntary Restrictions Increase
This article was originally published in The Tan Sheet
Executive Summary
A New York county adopts an ordinance limiting sales of dextromethorphan products to consumers 19 years old and up, while trade groups are looking to a uniform national solution that will curb abuse, maintain consumer access and limit retailer burdens
You may also be interested in...
Students’ OTC Cough/Cold Drug Abuse Steady, Monitoring Survey Says
Results of the latest national survey of students' illicit drug use show no change in the prevalence of young people abusing OTC cough and cold medicines, and the head researcher says "there is little evidence yet of much improvement" in preventing misuse
Biden DXM Bill Includes Age Limit, Bulk Ingredient Scheduling
The Consumer Healthcare Products Association backs Sen. Joe Biden's proposal to set a nationwide age limit on purchases of dextromethorphan-containing OTC drugs, but the group differs with the bill's approach to regulating bulk sales of raw DXM
CHPA Eyes DXM Action, FDA Revitalization, Imports As Congress Returns
In an Aug. 29 interview with "The Tan Sheet," Consumer Healthcare Products Association General Counsel Andy Fish, also the group's senior vice president of legal and government affairs, discussed CHPA's outlook during the rest of the congressional session for legislative activity that could affect the over-the-counter drug industry